Cargando…
P2X3 receptor antagonism attenuates the progression of heart failure
Despite advances in the treatment of heart failure, prognosis is poor, mortality high and there remains no cure. Heart failure is associated with reduced cardiac pump function, autonomic dysregulation, systemic inflammation and sleep-disordered breathing; these morbidities are exacerbated by periphe...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050083/ https://www.ncbi.nlm.nih.gov/pubmed/36977675 http://dx.doi.org/10.1038/s41467-023-37077-9 |
_version_ | 1785014603280809984 |
---|---|
author | Lataro, Renata M. Moraes, Davi J. A. Gava, Fabio N. Omoto, Ana C. M. Silva, Carlos A. A. Brognara, Fernanda Alflen, Lais Brazão, Vânia Colato, Rafaela Pravato do Prado, José Clóvis Ford, Anthony P. Salgado, Helio C. Paton, Julian F. R. |
author_facet | Lataro, Renata M. Moraes, Davi J. A. Gava, Fabio N. Omoto, Ana C. M. Silva, Carlos A. A. Brognara, Fernanda Alflen, Lais Brazão, Vânia Colato, Rafaela Pravato do Prado, José Clóvis Ford, Anthony P. Salgado, Helio C. Paton, Julian F. R. |
author_sort | Lataro, Renata M. |
collection | PubMed |
description | Despite advances in the treatment of heart failure, prognosis is poor, mortality high and there remains no cure. Heart failure is associated with reduced cardiac pump function, autonomic dysregulation, systemic inflammation and sleep-disordered breathing; these morbidities are exacerbated by peripheral chemoreceptor dysfunction. We reveal that in heart failure the carotid body generates spontaneous, episodic burst discharges coincident with the onset of disordered breathing in male rats. Purinergic (P2X3) receptors were upregulated two-fold in peripheral chemosensory afferents in heart failure, and when antagonized abolished these episodic discharges, normalized both peripheral chemoreceptor sensitivity and the breathing pattern, reinstated autonomic balance, improved cardiac function, and reduced both inflammation and biomarkers of cardiac failure. Aberrant ATP transmission in the carotid body triggers episodic discharges that via P2X3 receptors play a crucial role in the progression of heart failure and as such offer a distinct therapeutic angle to reverse multiple components of its pathogenesis. |
format | Online Article Text |
id | pubmed-10050083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-100500832023-03-30 P2X3 receptor antagonism attenuates the progression of heart failure Lataro, Renata M. Moraes, Davi J. A. Gava, Fabio N. Omoto, Ana C. M. Silva, Carlos A. A. Brognara, Fernanda Alflen, Lais Brazão, Vânia Colato, Rafaela Pravato do Prado, José Clóvis Ford, Anthony P. Salgado, Helio C. Paton, Julian F. R. Nat Commun Article Despite advances in the treatment of heart failure, prognosis is poor, mortality high and there remains no cure. Heart failure is associated with reduced cardiac pump function, autonomic dysregulation, systemic inflammation and sleep-disordered breathing; these morbidities are exacerbated by peripheral chemoreceptor dysfunction. We reveal that in heart failure the carotid body generates spontaneous, episodic burst discharges coincident with the onset of disordered breathing in male rats. Purinergic (P2X3) receptors were upregulated two-fold in peripheral chemosensory afferents in heart failure, and when antagonized abolished these episodic discharges, normalized both peripheral chemoreceptor sensitivity and the breathing pattern, reinstated autonomic balance, improved cardiac function, and reduced both inflammation and biomarkers of cardiac failure. Aberrant ATP transmission in the carotid body triggers episodic discharges that via P2X3 receptors play a crucial role in the progression of heart failure and as such offer a distinct therapeutic angle to reverse multiple components of its pathogenesis. Nature Publishing Group UK 2023-03-28 /pmc/articles/PMC10050083/ /pubmed/36977675 http://dx.doi.org/10.1038/s41467-023-37077-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Lataro, Renata M. Moraes, Davi J. A. Gava, Fabio N. Omoto, Ana C. M. Silva, Carlos A. A. Brognara, Fernanda Alflen, Lais Brazão, Vânia Colato, Rafaela Pravato do Prado, José Clóvis Ford, Anthony P. Salgado, Helio C. Paton, Julian F. R. P2X3 receptor antagonism attenuates the progression of heart failure |
title | P2X3 receptor antagonism attenuates the progression of heart failure |
title_full | P2X3 receptor antagonism attenuates the progression of heart failure |
title_fullStr | P2X3 receptor antagonism attenuates the progression of heart failure |
title_full_unstemmed | P2X3 receptor antagonism attenuates the progression of heart failure |
title_short | P2X3 receptor antagonism attenuates the progression of heart failure |
title_sort | p2x3 receptor antagonism attenuates the progression of heart failure |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050083/ https://www.ncbi.nlm.nih.gov/pubmed/36977675 http://dx.doi.org/10.1038/s41467-023-37077-9 |
work_keys_str_mv | AT latarorenatam p2x3receptorantagonismattenuatestheprogressionofheartfailure AT moraesdavija p2x3receptorantagonismattenuatestheprogressionofheartfailure AT gavafabion p2x3receptorantagonismattenuatestheprogressionofheartfailure AT omotoanacm p2x3receptorantagonismattenuatestheprogressionofheartfailure AT silvacarlosaa p2x3receptorantagonismattenuatestheprogressionofheartfailure AT brognarafernanda p2x3receptorantagonismattenuatestheprogressionofheartfailure AT alflenlais p2x3receptorantagonismattenuatestheprogressionofheartfailure AT brazaovania p2x3receptorantagonismattenuatestheprogressionofheartfailure AT colatorafaelapravato p2x3receptorantagonismattenuatestheprogressionofheartfailure AT dopradojoseclovis p2x3receptorantagonismattenuatestheprogressionofheartfailure AT fordanthonyp p2x3receptorantagonismattenuatestheprogressionofheartfailure AT salgadohelioc p2x3receptorantagonismattenuatestheprogressionofheartfailure AT patonjulianfr p2x3receptorantagonismattenuatestheprogressionofheartfailure |